GLP-1 drugs like Ozempic may have health benefits, but they come with risks
With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
MM&M1d
Novo Nordisk’s amycretin cuts weight by 22% in early obesity trial
The Danish pharma giant posted impressive data for amycretin one month after the disappointing readout of CagriSema.
Scientists find Ozempic may treat cancer, Alzheimer's and more. Is it hype or truly a "wonder drug?"
Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...
Medscape1d
A Guide for Discussing GLP-1s as Obesity Treatments
The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...
News Medical2d
Boosting BCL6 may counteract muscle loss from GLP-1 medications
About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal.
Science Daily2d
Boosting this molecule could help retain muscle while losing fat
With the recent surge in popularity of weight loss drugs like Ozempic, altogether called GLP-1s, there has been renewed scientific interest in understanding how our bodies regulate muscle growth.
The Root2d
The Internet is So Mad At Oprah About Weight Loss Comments. Here's The Tea
The media mogul is being criticized by some for statements she made about thin people on the latest episode of her podcast.
verywellhealth2d
What's Next for Alzheimer's Treatment? Some Scientists Are Betting on GLP-1 Drugs
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...
Boosting protein BCL6 could help GLP-1 users retain muscle while losing fat
About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users ...
Medscape2d
Obesity Medications: Who Needs Priority Access
A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
24/7 Wall St2d
I Was Convinced Biotech Stocks Were Too Risky—This Innovation's Changing the Game
The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough ...
Cooking With Nick on MSN2d
A High-Protein Recipe for GLP-1 Users: Delicious, Simple, and Satisfying
Hi there! If you’re here, chances are you’re on a GLP-1 medication like Ozempic, Wegovy, or Mounjaro, and you’re looking ...